Please use this identifier to cite or link to this item: doi:10.22028/D291-33799
Title: Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies
Author(s): Kovar, Lukas
Selzer, Dominik
Britz, Hannah
Benowitz, Neal
St. Helen, Gideon
Kohl, Yvonne
Bals, Robert
Lehr, Thorsten
Language: English
Title: Clinical Pharmacokinetics
Volume: 59
Issue: 9
Pages: 1119–1134
Publisher/Platform: Springer Nature
Year of Publication: 2020
DDC notations: 500 Science
610 Medicine and health
Publikation type: Journal Article
Abstract: Background Nicotine, the pharmacologically active substance in both tobacco and many electronic cigarette (e-cigarette) liquids, is responsible for the addiction that sustains cigarette smoking. With 8 million deaths worldwide annually, smoking remains one of the major causes of disability and premature death. However, nicotine also plays an important role in smoking cessation strategies. Objectives The aim of this study was to develop a comprehensive, whole-body, physiologically based pharmacokinetic/ pharmacodynamic (PBPK/PD) model of nicotine and its major metabolite cotinine, covering various routes of nicotine administration, and to simulate nicotine brain tissue concentrations after the use of combustible cigarettes, e-cigarettes, nicotine gums, and nicotine patches. Methods A parent–metabolite, PBPK/PD model of nicotine for a non-smoking and a smoking population was developed using 91 plasma and brain tissue concentration–time profles and 11 heart rate profles. Among others, cytochrome P450 (CYP) 2A6 and 2B6 enzymes were implemented, including kinetics for CYP2A6 poor metabolizers. Results The model is able to precisely describe and predict both nicotine plasma and brain tissue concentrations, cotinine plasma concentrations, and heart rate profles. 100% of the predicted area under the concentration–time curve (AUC) and maximum concentration (Cmax) values meet the twofold acceptance criterion with overall geometric mean fold errors of 1.12 and 1.15, respectively. The administration of combustible cigarettes, e-cigarettes, nicotine patches, and nicotine gums was successfully implemented in the model and used to identify diferences in steady-state nicotine brain tissue concentration patterns. Conclusions Our PBPK/PD model may be helpful in further investigations of nicotine dependence and smoking cessation strategies. As the model represents the frst nicotine PBPK/PD model predicting nicotine concentration and heart rate profles after the use of e-cigarettes, it could also contribute to a better understanding of the recent increase in youth e-cigarette use.
DOI of the first publication: 10.1007/s40262-020-00880-4
Link to this record: urn:nbn:de:bsz:291--ds-337998
hdl:20.500.11880/31126
http://dx.doi.org/10.22028/D291-33799
ISSN: 1179-1926
0312-5963
Date of registration: 12-Apr-2021
Description of the related object: Electronic supplementary material
Related object: https://static-content.springer.com/esm/art%3A10.1007%2Fs40262-020-00880-4/MediaObjects/40262_2020_880_MOESM1_ESM.pdf
Faculty: M - Medizinische Fakultät
NT - Naturwissenschaftlich- Technische Fakultät
Department: M - Innere Medizin
NT - Pharmazie
Professorship: M - Prof. Dr. Robert Bals
NT - Prof. Dr. Thorsten Lehr
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
Kovar2020_Article_ComprehensiveParentMetaboliteP.pdf2,88 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons